Wyeth Limited, a prominent player in the pharmaceutical and biotechnology industry, is headquartered in India. Established in 1860, the company has a rich history marked by significant milestones, including its evolution into a leader in healthcare solutions. Wyeth Limited primarily focuses on the development and manufacturing of innovative pharmaceuticals, vaccines, and nutritional products, catering to diverse health needs. With a strong presence in major operational regions across India and beyond, Wyeth Limited is renowned for its commitment to quality and research-driven approaches. The company’s core offerings, including advanced vaccines and nutritional supplements, are distinguished by their efficacy and safety. Recognised for its market leadership, Wyeth Limited continues to make strides in improving health outcomes, solidifying its reputation as a trusted name in the healthcare sector.
How does Wyeth Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Wyeth Limited's score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Wyeth Limited, headquartered in India, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a merged entity and inherits its performance data from Pfizer Limited, which is at a cascade level of 1. However, there are no documented reduction targets or climate pledges available for Wyeth Limited at this time. As part of the broader industry context, companies like Wyeth Limited are increasingly expected to adopt robust climate commitments and transparency in emissions reporting. While specific initiatives or targets are not outlined for Wyeth, the parent company, Pfizer Limited, may have its own climate strategies that could influence Wyeth's future commitments. In summary, Wyeth Limited currently lacks specific emissions data and reduction targets, reflecting a growing need for enhanced climate action and accountability within the pharmaceutical sector.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Wyeth Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

